ARTHUR PRZYBYL
CIK 1268135 · President and CEO · last filed 2020-04-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.24M
Companies
5
Total Filings
71
Lifetime Open-Market Net
-$15.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIP | President and CEO | 192,424 | $79.20 | $15.24M | -$4.60M | 42 | 2020-04-08 |
| ANI PHARMACEUTICALS INC (FOLD) Delisted | President and CEO | 202,589 | $14.49 | $2.94M | -$10.31M | 19 | 2019-05-15 |
| ANI PHARMACEUTICALS INC (BPAX) Delisted | President and CEO | 327,748 | — | — | $0 | 2 | 2013-07-16 |
| AKORN INC (AKRX) Delisted | President, CEO | 850,445 | — | — | -$930.2K | 7 | 2009-01-02 |
| AKORN INC (AKN) Delisted | President, CEO | — | — | — | $0 | 1 | 2007-01-04 |
Recent Filings · Page 2 of 8
71 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-04-10 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Mixed | +27,086 | -$114.9K | EDGAR |
| 2018-04-03 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Tax (F) | −2,550 | -$148.5K | EDGAR |
| 2018-03-14 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Mixed | −24,277 | -$2.37M | EDGAR |
| 2018-03-05 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Mixed | — | -$825.4K | EDGAR |
| 2017-05-24 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Tax (F) | −991 | -$46.6K | EDGAR |
| 2017-04-18 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Tax (F) | −1,161 | -$59.5K | EDGAR |
| 2017-04-11 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Tax (F) | −1,451 | -$74.3K | EDGAR |
| 2017-04-04 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Mixed | +22,630 | $0 | EDGAR |
| 2016-08-23 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Mixed | +15,723 | -$1.83M | EDGAR |
| 2016-08-09 | ANI PHARMACEUTICALS INC (FOLD) Delisted | Gift (G) | −836 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.